Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Minister for the Cabinet Office, how many covid-19 related deaths were recorded in care homes in the London Borough of Redbridge in each month in 2020.
Answered by Chloe Smith
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Minister for the Cabinet Office, how many deaths in care homes have been recorded in the London borough of Redbridge in each month since January 2020.
Answered by Chloe Smith
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Minister for the Cabinet Office, how many deaths in care homes were recorded in the London borough of Redbridge in each month in 2019.
Answered by Chloe Smith
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, how many meetings each Cabinet committee has held since the Prime Minister took office.
Answered by Oliver Dowden
It is a long established precedent that information about the discussions that have taken place in Cabinet and its Committees, and how often they have met, is not shared publicly.
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, how many meetings each Cabinet committee has held since the Prime Minister took office.
Answered by Kevin Foster
Cabinet committees meet on a regular basis to discuss government business. Since the Prime Minister took office this has continued.
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, when he plans to provide a substantive answer to Question 286311, tabled on 3 September 2019 by the hon. Member for Ilford North.
Answered by Kevin Foster
If we have to leave with no deal, there will not be an overall shortage of food in the UK. Consumers have access to a wide range of food products when they shop and this will continue once we leave the EU.
As a responsible Government, we are preparing for the possibility of no-deal and have put in place plans to minimise disruption for the food and farming sector as much as possible.
Whilst the capability to ensure resilience and security of food supply is industry-led, Government has well established ways of working with the food industry to minimise potential disruption, including liaison through the Food Chain Emergency Liaison Group (FCELG).
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Cabinet Office:
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, when he plans to provide a substantive answer to Question 286312, tabled on 3 September 2019 by the hon. Member for Ilford North.
Answered by Kevin Foster
Our highest priority is for patients to continue to have access to medicines and medical products.
DHSC has contacted 448 suppliers of medicines with an EU touchpoint in their supply chain and more than 1300 suppliers of medical devices and clinical consumables in order to understand their supply chains and their proposed contingency measures.
DHSC is implementing a multi-layered approach to minimise any supply disruption in a ‘no deal’ exit scenario. This includes supporting suppliers to secure alternative routes away from the short straits, stockpiling where practical, putting in place arrangements to deal with shortages in addition to normal shortage management routes, securing additional warehousing space, improving trader readiness and introducing regulatory flexibility.
Our plans should ensure the supply of medicines and medical products remains uninterrupted.